Author:Guled, Fatuma HassanDate:2018An effective antibody-based HIV-1 vaccine would ideally elicit potent antibodies capable of neutralising a wide range of HIV-1 isolates to better cover the human population. A primary concern is the virus’ ability to rapidly escape an antibody ...Read more
Author:Harvey, Hayley JanetDate:2011In this thesis we aimed to determine the timing and frequency of intra-subtype C superinfection, and to determine if the reason for superinfection was a greater genetic distance within epitopes of the superinfecting virus compared to those ...Read more
Author:Ismail, Sherazaan DineoDate:2016The CAPRISA 004 trial demonstrated the safety and a 39% efficacy of a 1% tenofovir (TFV) gel for the prevention of HIV-1 acquisition in young African women. It was subsequently shown that women assigned to the TFV arm who became infected had ...Read more
Author:Williamson, CarolynDate:1988A new aphid virus, aphid lethal paralysis virus (ALPV), was isolated from laboratory-propagated Rhopalosiphum padi aphids co-infected with R. padi virus (RhPV). ALPV and RhPV were separated and ALPV was characterised in detail. Virions are ...Read more
Author:Ismail, Sherazaan DineoDate:2022Since the advent of antiretroviral therapy (ART) and the resultant suppression of viraemia in the majority of people living with HIV-1 (PLWH) on ART, HIV-1 infection has become manageable and PLWH have similar life expectancies as uninfected ...Read more
Author:Majara, Lerato CharlotteDate:2016It is widely held that for an HIV-1 vaccine to provide sterilizing immunity, it would need to elicit broadly neutralizing antibodies (bnAbs). However, factors underlying the development of these antibodies are not clear. There is evidence to ...Read more
Author:Van Harmelen, Joanne HeidiDate:1999The overall aim of this project was to investigate HIV-1 genetic diversity in South Afri ca and to characterise the immune response in mice to a South African subtype C gp120. To investigate the relationship between subtype and mode of ...Read more
Author:Martin, Darren; Williamson, CarolynDate:2004Transmission of an HIV-like virus from chimpanzees to humans approximately 80 years ago triggered the worldwide AIDS pandemic. Possessing very high mutation and recombination rates, the descendants of this ancestral virus have evolved greatly. ...Read more
Author:Chopera, Denis RutendoDate:2009Most HIV vaccines currently in development aim to protect people from infection or disease by eliciting strong anti-HIV cytotoxic T lymphocyte (CTL) responses. Evolved evasion mutations that undermine host immune responses pose a major challenge ...Read more